Your browser doesn't support javascript.
loading
Sodium hyaluronate 0.30% ocular gel versus sodium hyaluronate 0.18% eye drop in the treatment of moderate to severe dry eye disease.
Calonge, Margarita; Sahyoun, Marwan; Baillif, Stéphanie; Gain, Philippe; Paw, Ewa; Mearza, Ali; Cochener, Béatrice.
Affiliation
  • Calonge M; 537068IOBA (Institute of Applied Ophthalmobiology), University of Valladolid, Valladolid, Spain.
  • Sahyoun M; 203346CIBER-BBN (Biomedical Research Networking Center Bioengineering, Biomaterials and Nanomedicine), Carlos III National Institute of Health, Spain.
  • Baillif S; Horus Pharma, Saint-Laurent-du-Var, France.
  • Gain P; Pasteur 2 University Hospital, 37045Côte d'Azur University, Nice, France.
  • Paw E; CHU de Saint-Etienne, Saint-Priest-en-Jarez, France.
  • Mearza A; Eurofins Dermscan Poland Sp. z o. o., Gdansk, Poland.
  • Cochener B; 8946Imperial College Healthcare NHS Trust, London, UK.
Eur J Ophthalmol ; 33(1): 188-195, 2023 Jan.
Article in En | MEDLINE | ID: mdl-35450456

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Dry Eye Syndromes / Hyaluronic Acid Type of study: Clinical_trials Limits: Humans Language: En Journal: Eur J Ophthalmol Journal subject: OFTALMOLOGIA Year: 2023 Document type: Article Affiliation country: Spain

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Dry Eye Syndromes / Hyaluronic Acid Type of study: Clinical_trials Limits: Humans Language: En Journal: Eur J Ophthalmol Journal subject: OFTALMOLOGIA Year: 2023 Document type: Article Affiliation country: Spain